Replidyne, a successful biopharmaceutical company has chosen Baker Communications to provide presentations training to their market researchers. The Exceptional Presentations course will give market researchers critical skills such as the Power Position, the Four Ps, and handling objections. During the training, participants will learn how to fully prepare, and then deliver, effective presentations by working with senior instructors to evaluate themselves through the use of digitally video recorded sessions. The interactive nature of the Exceptional Presentations workshop will empower participants to deliver presentations with confidence and success.
Senior level Baker instructors will arrive in Broomfield, Colorado to engage Replidyne market researchers. Replidyne selected Baker Communications for Baker’s commitment to Replidyne’s special needs, as well as for Baker’s ability to fully tailor the Exceptional Presentations training to completely meet those needs.
About Baker Communications
Baker Communications designs and deploys Peak Performance and Transformation Solutions that ignite and sustain growth. As one of the fastest growing Performance Improvement companies in the world, Baker Communications delivers innovative products and services in eight areas including Sales, Marketing, CRM, Negotiations, Presentations, Management, Customer Service, and Time Management. Over 1,000 corporations per year, including 50% of the Fortune 500, partner with Baker Communications to improve the performance of their business critical functions and human capital. Our employees and certified partners are distributed across the Americas, EMEA, Russia and Asia, enabling us to deliver value in multiple geographies, languages and cultures. Baker Communications has been recognized as one of the world’s “Top 10 Sales Force Automation Training Companies” and “Top 20 Sales Training Companies.”
About Replidyne
Replidyne is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products. Founded in 2000, Replidyne is headquartered in Louisville, Colorado and maintains a strong focus on discovery research. All research and development, manufacturing, business development, commercial and operational functions operate out of Colorado, while Replidyne’s clinical and regulatory development group is based in Milford, Connecticut. The team’s depth of professional experience in drug development, especially in the area of anti-infective products, positions Replidyne to quickly and successfully meet the current challenges of anti-infective drug development.
Baker Communications, Inc. — Houston, Texas
info@thebciteam.com —
www.bakercommunications.com
